Եվրոպական Միություն -
իտալերեն -
EMA (European Medicines Agency)
herwenda
sandoz gmbh - trastuzumab - breast neoplasms; stomach neoplasms - agenti antineoplastici - treatment of metastatic and early breast cancer and metastatic gastric cancer (mgc).
Շվեյցարիա -
իտալերեն -
Swissmedic (Swiss Agency for Therapeutic Products)
xolair 75 mg polvere e solvente per soluzione iniettabile
novartis pharma schweiz ag - omalizumabum - polvere e solvente per soluzione iniettabile - praeparatio cryodesiccata: omalizumabum 75 mg, histidini hydrochloridum monohydricum, histidinum, saccharum, polysorbatum 20, pro vitro. solvens: aqua ad iniectabile 2 ml. - allergisches asthma, chronische spontane urtikaria, nasenpolypen - biotechnologika
Շվեյցարիա -
իտալերեն -
Swissmedic (Swiss Agency for Therapeutic Products)
xolair 150 mg polvere e solvente per soluzione iniettabile
novartis pharma schweiz ag - omalizumabum - polvere e solvente per soluzione iniettabile - praeparatio cryodesiccata: omalizumabum 150 mg, histidini hydrochloridum monohydricum, histidinum, saccharum, polysorbatum 20, pro vitro. solvens: aqua ad iniectabile. - allergisches asthma, chronische spontane urtikaria, nasenpolypen - biotechnologika
Շվեյցարիա -
իտալերեն -
Swissmedic (Swiss Agency for Therapeutic Products)
synagis 50 mg injektionspräparat
abbvie ag - palivizumabum - injektionspräparat - preparazione cryodesiccata: palivizumabum 73 mg, glycinum, histidinum, mannitolum, per il vetro. rilascio: acqua iniectabilia, per il vetro, corrisp. soluzione reconstituta 0,5 ml con palivizumabum 50 mg. - rsv-prophylaxe - biotechnologika
Շվեյցարիա -
իտալերեն -
Swissmedic (Swiss Agency for Therapeutic Products)
synagis 100 mg injektionspräparat
abbvie ag - palivizumabum - injektionspräparat - preparazione cryodesiccata: palivizumabum 122 mg, glycinum, histidinum, mannitolum, per il vetro. rilascio: acqua iniectabilia, per il vetro, corrisp. soluzione reconstituta 1 ml con palivizumabum 100 mg. - rsv-prophylaxe - biotechnologika
Եվրոպական Միություն -
իտալերեն -
EMA (European Medicines Agency)
epysqli
samsung bioepis nl b.v. - eculizumab - emoglobinuria, parossistica - immunosoppressori - epysqli is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history.
Եվրոպական Միություն -
իտալերեն -
EMA (European Medicines Agency)
phesgo
roche registration gmbh - pertuzumab, trastuzumab - neoplasie al seno - agenti antineoplastici - early breast cancer (ebc)phesgo is indicated for use in combination with chemotherapy in:the neoadjuvant treatment of adult patients with her2-positive, locally advanced, inflammatory, or early stage breast cancer at high risk of recurrencethe adjuvant treatment of adult patients with her2-positive early breast cancer at high risk of recurrencemetastatic breast cancer (mbc)phesgo is indicated for use in combination with docetaxel in adult patients with her2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-her2 therapy or chemotherapy for their metastatic disease.
Շվեյցարիա -
իտալերեն -
Swissmedic (Swiss Agency for Therapeutic Products)
herzuma 440 mg polvere per soluzione per infusione
iqone healthcare switzerland sa - trastuzumabum - polvere per soluzione per infusione - praeparatio cryodesiccata: trastuzumabum 440 mg, trehalosum dihydricum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 20, pro vitro. solvant (i.v.): alcohol benzylicus 0.22 g, aqua ad iniectabile, q.s. ad solutionem pro 20 ml. - oncologique - biotechnologika
Շվեյցարիա -
իտալերեն -
Swissmedic (Swiss Agency for Therapeutic Products)
herzuma 150 mg polvere per soluzione per infusione
iqone healthcare switzerland sa - trastuzumabum - polvere per soluzione per infusione - praeparatio cryodesiccata: trastuzumabum 150 mg, trehalosum dihydricum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 20, pro vitro. - oncologique - biotechnologika
Եվրոպական Միություն -
իտալերեն -
EMA (European Medicines Agency)
ipique
rotterdam biologics b.v. - bevacizumab - degenerazione maculare umida - oftalmologici - treatment of neovascular (wet) age-related macular degeneration (amd).